Healthcare provider profile · identity verified

Carly Dion Waren, ARNP

Nurse Practitioner · CUSHING, OK · NPI 1902103492

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	188	45
Lisinopril	Lisinopril	162	42
Gabapentin	Gabapentin	152	34
Metformin Hcl	Metformin Hcl	128	30
Atorvastatin Calcium	Atorvastatin Calcium	116	35
Omeprazole	Omeprazole	113	33
Montelukast Sodium	Montelukast Sodium	85	23
Pantoprazole Sodium	Pantoprazole Sodium	82	15
Amlodipine Besylate	Amlodipine Besylate	79	21
Simvastatin	Simvastatin	76	16
Albuterol Sulfate Hfa	Albuterol Sulfate	74	22
Tramadol Hcl	Tramadol Hcl	74	14
Losartan Potassium	Losartan Potassium	70	17
Clonazepam	Clonazepam	69	suppressed
Sertraline Hcl	Sertraline Hcl	61	18
Hydrochlorothiazide	Hydrochlorothiazide	55	15
Alprazolam	Alprazolam	53	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	53	suppressed
Carvedilol	Carvedilol	50	13
Mounjaro	Tirzepatide	49	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	44	14
Doxycycline Hyclate	Doxycycline Hyclate	42	29
Duloxetine Hcl	Duloxetine Hcl	42	11
Metoprolol Tartrate	Metoprolol Tartrate	39	suppressed
Clopidogrel	Clopidogrel Bisulfate	38	suppressed
Diclofenac Sodium	Diclofenac Sodium	38	suppressed
Trazodone Hcl	Trazodone Hcl	37	suppressed
Potassium Chloride	Potassium Chloride	36	11
Venlafaxine Hcl Er	Venlafaxine Hcl	35	suppressed
Alendronate Sodium	Alendronate Sodium	34	suppressed
Furosemide	Furosemide	34	11
Ozempic	Semaglutide	34	suppressed
Eliquis	Apixaban	33	suppressed
Allopurinol	Allopurinol	32	suppressed
Buspirone Hcl	Buspirone Hcl	31	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	31	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	30	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	29	18
Fluconazole	Fluconazole	28	13
Celecoxib	Celecoxib	27	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	27	suppressed
Metoprolol Succinate	Metoprolol Succinate	27	suppressed
Trulicity	Dulaglutide	27	suppressed
Bupropion Xl	Bupropion Hcl	25	suppressed
Fluticasone Propionate	Fluticasone Propionate	24	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	24	suppressed
Naproxen	Naproxen	23	suppressed
Promethazine Hcl	Promethazine Hcl	23	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	22	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Acyclovir	Acyclovir	20	suppressed
Glyburide	Glyburide	20	suppressed
Jardiance	Empagliflozin	20	suppressed
Meloxicam	Meloxicam	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Azithromycin	Azithromycin	19	16
Citalopram Hbr	Citalopram Hydrobromide	18	suppressed
Eszopiclone	Eszopiclone	18	suppressed
Temazepam	Temazepam	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	suppressed
Fenofibrate	Fenofibrate	17	suppressed
Glipizide	Glipizide	16	suppressed
Atenolol	Atenolol	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Baclofen	Baclofen	14	suppressed
Methylprednisolone	Methylprednisolone	14	12
Spiriva Handihaler	Tiotropium Bromide	14	suppressed
Topiramate	Topiramate	14	suppressed
Cephalexin	Cephalexin	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Estradiol	Estradiol	12	suppressed
Invega Sustenna	Paliperidone Palmitate	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Vraylar	Cariprazine Hcl	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Invokana	Canagliflozin	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Prazosin Hcl	Prazosin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error